Paper36040035
Arteannuin B Enhances the Effectiveness of Cisplatin in Non-Small Cell Lung Cancer by Regulating Connexin 43 and MAPK Pathway.
Huang W and 11 others. Am J Chin Med, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Arteannuin B Enhances the Effectiveness of Cisplatin in Non-Small Cell Lung Cancer by Regulating Connexin 43 and MAPK Pathway. Papers, record 36040035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36040035
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Arteannuin B Enhances the Effectiveness of Cisplatin in Non-Small Cell Lung Cancer by Regulating Connexin 43 and MAPK Pathway.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cisplatin | |
| Connexin 43 | |
| Drug Resistance, Neoplasm | |
| MAP Kinase Signaling System | |
| Artemisinins |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42524207 | Arteannuin B Induces Ferroptosis in Colorectal Cancer Cells via GDF15/HMGCS1/GPX4 Axis. | J Cancer | 2026 | https://conductscience.org/library/papers/42524207 | PubMed |
| 41981457 | Arteannuin B Inhibits NSCLC Cells via Regulating miR-194-3p/CLDN2 Axis. | Cancer Med | 2026 | https://conductscience.org/library/papers/41981457 | PubMed |
| 41524971 | AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/41524971 | PubMed |
| 40416989 | Bibliometric analysis and visualization of Connexin 43 in the field of solid tumor research(2000-2024). | Front Immunol | 2025 | https://conductscience.org/library/papers/40416989 | PubMed |
| 40286231 | Green Extraction of Volatile Terpenes from Artemisia annua L. | Molecules | 2025 | https://conductscience.org/library/papers/40286231 | PubMed |
| 39394878 | Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis. | Cancer Med | 2024 | https://conductscience.org/library/papers/39394878 | PubMed |
| 38792963 | Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC). | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38792963 | PubMed |
| 38191768 | Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation. | Cancer Chemother Pharmacol | 2024 | https://conductscience.org/library/papers/38191768 | PubMed |
| 36772869 | ITGB3 promotes cisplatin resistance in osteosarcoma tumors. | Cancer Med | 2023 | https://conductscience.org/library/papers/36772869 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GJA1 | 2697 | PubTator's text mining | https://conductscience.org/library/genes/2697 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36040035
GET https://conductscience.org/api/papers/v1/36040035/authors